İleri evre pelvik organ proplapsusu olan kadınlarda yaşam kalitesi ve cinsel yaşam

Year 2018, Volume: 43 Number: Supplement 1, 230 - 239, 29.12.2018

Burcu Avcıbay Vurgeç , Nezihe Kızılkaya Beji

https://doi.org/10.17826/cumj.427253

Cited By: 4

Abstract

Amaç: Bu çalışmanın amacı, pelvik organ prolapsusu olan kadınları risk faktörleri bakımından değerlendirmek ve prolapsusunun yaşam kalitesi ile cinsel fonksiyon üzerindeki etkilerini belirlemektir.

Gereç ve Yöntem: Araştırmanın örneklemini, bir üniversite hastanesi ile kadın doğum ve çocuk hastanesindeki jinekoloji polikliniğine başvuran kadınlar oluşturmuştur. Çalışma 81 vaka ve 110 kontrol grubu katılımcı ile tamamlanmıştır. Veriler, kadınları tanıtıcı bilgi formu, Pelvik Taban Distres Envanteri- 20 (PFDI-20), Prolapsus Yaşam Kalitesi Ölçeği (P-QoL), Pelvik Organ Prolapsusu / Üriner İnkontinans Cinsel İşlev Ölçeği (PISQ-12) ve Kadın Cinsel Fonksiyonu İndeksi (FSFI) aracılığıyla toplanmıştır. 

Bulgular: Çalışma sonuçları pelvik taban disfonksiyonu arttıkça yaşam kalitesinin azaldığını ve cinsel fonksiyonun olumsuz yönde etkilendiğini göstermektedir. Vaka ve kontrol grubu arasındaki yaşam kalitesi ve cinsel disfonksiyon ölçek genel puan ortalamaları arasındaki fark istatistiksel olarak anlamlıdır. POP prevalansı, gebelik sayısında azalma ile 1.6 kat, doğum sayısındaki azalma ile 3.5 kat azalırken ve müdahaleli doğumda 2.8 kat, aile öyküsü varsa 5.8 kat artmaktadır.

Sonuç: Pelvik taban disfonksiyonu ile yaşam kalitesi ve cinsellik arasındaki ilişki göz önüne alındığında, bunun sadece bir tıbbi sorun değil aynı zamanda sosyal bir sorun olduğunu söylemek mümkündür. Bu bakımdan, hem sağlık çalışanlarının hem de kadınların POP ile karşılaşma riskini azaltma açısından riskler hakkında önceden bilgi sahibi olmaları önemlidir.

Keywords

Pelvik organ prolapsusu, yaşam kalitesi, cinsel yaşam, cinsel sağlık

Quality of life and sexual life in women with advanced stage pelvic organ prolapse

Abstract

Purpose: This study aims to evaluate women with pelvic organ prolapse in terms of the risk factors and identify the effects of pelvic organ prolapse on quality of life and sexual function. 

Materials and Methods: Target population of the study was women who applied to the gynecology polyclinics in a university hospital and maternity and children hospital. The study was completed with 110 control and 81 case group participants. The data were collected through Personal Identification Form, Pelvic Floor Distress Inventroy-20 (PFDI-20), Prolapse Quality of Life Scale (P-QOL), Pelvic Organ Prolapse / Urinary Incontinence Sexual Function Questionnaire (PISQ-12) and Female Sexual Function Inventory (FSFI).  

Results: Study results show that as pelvic floor dysfunction increases, quality of life decreases and sexual function is affected negatively. The difference in the general mean scores of questionnaires life quality and sexual dysfunction between the case and control groups was found to be statistically significant. POP prevalence decreases 1.6 times with the decrease in the number of pregnancies; it decreases 3.5 times with the decrease in the number of deliveries; and assisted delivery increases 2.8 times and increases 5.8 times if there is family history.

Conclusion: Given the relationship between pelvic floor dysfunction and quality of life and sexuality it is possible to say that this is not only a medical problem but also a social problem. In this regard, it is important that both health professionals and women have prior knowledge of the risks about in terms of reducing the risk of encountering POP.

Keywords

Pelvic organ prolapse, quality of life, sexual life, sexual health

References

• 1. Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016; 27(4):655-84.
• 2. Novi JM, Jeronis S, Morgan MA, Arya LA. Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse. J Urol 2005; 173(5):1669-72.
• 3. Barber MD, Visco AG, Wyman JF, Fantl JA, Bump RC. Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol 2002; 99 (2):281-89.
• 4. Tok EC, Yasa O, Ertunc D, Savas A, Durukan H, Kanik A. The effects of pelvic organ prolapse on sexual function in a general cohort of women. J Sex Med 2010; 7(12):3957-62.
• 5. Zielinski R, Miller J, Low LK, Sampselle C, DeLancey JO. The relationship between pelvic organ prolapse, genital body image, and sexual health. Neurourol Urodyn 2012; 31(7):1145-8.
• 6. Celik DB, Kizilkaya Beji N, Yalcin O. Sexual function in women after urinary incontinence and/or pelvic organ prolapse surgery. J Clin Nurs 2014; 23(17-18):2637-48.
• 7. Chow D, Rodríguez LV. Epidemiology and prevalence of pelvic organ prolapse. Curr Opin Urol 2013; 23(4):293-98.
• 8. Mothes AR, Radosa MP, Altendorf-Hofmann A, Runnebaum IB. Risk index for pelvic organ prolapse based on established individual risk factors. Arch Gynecol Obstet 2016; 293(3):617-24.
• 9. Nygaard I, Bradley C, Brandt D, Women's Health Initiative. Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 2004; 104(3):489-97.10. Miedel A, Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol 2009; 113(5):1089-97.
• 11. Lince SL, van Kempen LC, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J 2012; 23(10):1327-36.
• 12. Nikolova G, Lee H, Berkovitz S, Nelson S, Sinsheimer J, Vilain E, Rodríguez LV. Sequence variant in the laminin γ1 (LAMC1) gene associated with familial pelvic organ prolapse. Hum Genet 2007; 120(6):847-56.
• 13. Chen HY, Chung YW, Lin WY, Chen WC, Tsai FJ, Tsai CH. Estrogen receptor alpha polymorphism is associated with pelvic organ prolapse risk. Int Urogynecol J Pelvic Floor Dysfunc 2008; 19 (8):1159-63.
• 14. Martins Kde F, de Jármy-DiBella ZI, da Fonseca AM, Castro RA, da Silva ID, Girão MJ, et al. Evaluation of demographic, clinical characteristics, and genetic polymorphism as risk factors for pelvic organ prolapse in Brazilian women. Neurourol Urodyn 2011; 30(7):1325-8.
• 15. Espuna-Pons M, Fillol M, Pascual MA, Rebollo P, Mora AM. Pelvic floor symptoms and severity of pelvic organ prolapse in women seeking care for pelvic floor problems. Eur J Obstet Gynecol Reprod Biol 2014; 177:141-5.
• 16. Awwad J, Sayegh R, Yeretzian, J, Deeb ME. Prevalence, risk factors, and predictors of pelvic organ prolapse: a community-based study. Menopause 2012; 19(11):1235-41.
• 17. Kudish BI, Iglesia CB, Gutman RE, Sokol AI, Rodgers AK, Gass M, et al. Risk factors for prolapse development in white, black, and Hispanic women. Female Pelvic Med Reconstr Surg 2011; 17(2):80-90.
• 18. Dietz HP. The aetiology of prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19(10):1323-9.
• 19. Zargham M, Alizadeh F, Moayednia A, Haghdani S, Nouri-Mahdavi K. The role of pelvic organs prolapse in the etiology of urinary incontinence in women. Adv Biomed Res 2013; 6(2):22.
• 20. Rodríguez-Mias NL, Martínez-Franco E, Aguado J, Sánchez E, Amat-Tardiu L. Pelvic organ prolapse and stress urinary incontinence, do they share the same risk factors?. Eur J Obstet Gynecol Reprod Biol 2015; 190:52-7.
• 21. Trutnovsky G, Kamisan Atan I, Martin A, Dietz HP. Delivery mode and pelvic organ prolapse: a retrospective observational study. BJOG 2015; 123(9):1551-6.
• 22. Handa VL, Blomquist JL, McDermott KC, Friedman S, Muñoz A. Pelvic floor disorders after childbirth: Effect of episiotomy, perineal laceration, and operative birth. Obstet Gynecol 2012; 119(2 Pt 1):233-9.
• 23. Gyhagen M, Bullarbo M, Nielsen TF, Milsom I. Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery. BJOG 2013; 120(2):152-60.
• 24. Pizarro‐Berdichevsky J, Hitschfeld MJ, Pattillo A, Blumel B, Gonzalez S, Arellano M, et al. Association between pelvic floor disorder symptoms and QoL scores with depressive symptoms among pelvic organ prolapse patients. Aust N Z J Obstet Gynaecol 2016; 56(4):391-7.
• 25. Teleman P, Laurikainen E, Kinne I, Pogosean R, Jakobsson U, Rudnicki M. Relationship between the Pelvic Organ Prolapse Quantification system (POP-Q), the Pelvic Floor Impact Questionnaire (PFIQ-7), and the Pelvic Floor Distress Inventory (PFDI-20) before and after anterior vaginal wall prolapse surgery. Int Urogynecol J 2015; 26(2):195-200.
• 26. Ghetti C, Lee M, Oliphant S, Okun M, Lowder JL. Sleep quality in women seeking care for pelvic organ prolapse. Maturitas 2015; 80(2):155-61.
• 27. Svihrova V, Svihra J, Luptak J, Swift S, Digesu GA. Disability-adjusted life years (DALYs) in general population with pelvic organ prolapse: a study based on the prolapse quality-of-life questionnaire (P-QOL). Eur J Obstet Gynecol Reprod Biol 2014; 182:22-6.
• 28. Digesu GA, Khullar V, Cardozo L, Robinson D, Salvatore S. P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2014; 16(3):176-81.
• 29. Fritel X, Varnoux N, Zins M, Breart G, Ringa V. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol 2009; 113(3):609-16.
• 30. Siff LN, Jelovsek JE, Barber MD. The effect of major depression on quality of life after surgery for stress urinary incontinence: a secondary analysis of the Trial of Midurethral Slings. Am J Obstet Gynecol 2016; 215(4):455.e1-9.